文献速递乳房整形与再造

直接置入假体胸肌前乳房再造:患者报告结局

Direct-to-Implant Prepectoral Breast Reconstruction: Patient-Reported Outcomes.
PubMed 文献 · Plast Reconstr Surg · 2021-01-01

本研究纳入69例成年患者共110侧直接置入假体胸肌前乳房再造,术前及术后6、12个月完成BREAST-Q问卷。乳房满意度从术前61.3降至12个月58.6(p=0.32),社会心理幸福感从67.1升至71.1(p=0.26),胸部生理幸福感从74.4降至73.3(p=0.62),性幸福感从60.2降至59.1(p=0.80)。脱细胞真皮基质和放疗对患者报告结局无显著影响,新辅助化疗、年龄增加和波纹征对BREAST-Q结果有负面影响。

要点

  • 直接置入假体胸肌前乳房再造后12个月乳房满意度较术前无显著变化(61.3 vs 58.6,p=0.32)。
  • 社会心理幸福感从术前67.1改善至12个月71.1,但未达统计学显著(p=0.26)。
  • 新辅助化疗、年龄增加和波纹征对BREAST-Q结果有负面影响。

核心结论

  • 接受直接置入假体胸肌前乳房再造的患者对结局总体满意。

研究设计与样本

  • 本研究为治疗性研究,证据等级IV。
  • 69例同意参与的成年患者共接受110侧直接置入假体胸肌前乳房切除后再造。
  • 患者在术前、术后6个月和12个月完成BREAST-Q问卷。

主要发现

  • 乳房满意度均值从术前61.3降至再造后12个月58.6(p=0.32),无统计学显著差异。
  • 社会心理幸福感从术前67.1改善至12个月随访71.1(p=0.26),无统计学显著差异。
  • 胸部生理幸福感从74.4变为12个月随访73.3(p=0.62),无统计学显著差异。
  • 性幸福感从术前60.2变为12个月59.1(p=0.80),无统计学显著差异。
  • 脱细胞真皮基质和乳房切除术后放疗对患者报告结局无显著影响;回归分析显示新辅助化疗、年龄增加和波纹征发生率对BREAST-Q结果有负面影响。

临床怎么用

  • 作者认为,随着胸肌前乳房再造不断发展和普及,本研究呈现的患者报告结局在临床实践中至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Direct-to-implant prepectoral breast reconstruction has recently experienced a resurgence in popularity because of its lower levels of postoperative pain and animation deformity. BREAST-Q, a well-validated patient-reported outcomes tool, was used to assess patient satisfaction and quality of life. The goal of this study was to assess patient-reported outcomes at 6-month and 1-year follow-up after direct-to-implant prepectoral breast reconstruction. METHODS: Sixty-nine consented adult patients undergoing a total of 110 direct-to-implant, prepectoral, postmastectomy breast reconstructions completed BREAST-Q questionnaires immediately preoperatively, and at 6 and 12 months thereafter. RESULTS: Mean breast satisfaction decreased nonsignificantly from 61.3 preoperatively to 58.6 at 12 months after reconstruction (p = 0.32). Psychosocial well-being improved nonsignificantly from 67.1 preoperatively to 71.1 at 12-month follow-up (p = 0.26). Physical well-being of the chest was insignificantly different, from 74.4 to 73.3 at 12-month follow-up (p = 0.62). Finally, sexual well-being similarly remained nonsignificantly changed from 60.2 preoperatively, to 59.1 at 12 months (p = 0.80). The use of acellular dermal matrix and postmastectomy radiotherapy did not have any significant effects on patient-reported outcomes. Through regression analysis, neoadjuvant chemotherapy, increased age, and incidence of rippling were found to negatively influence BREAST-Q results. CONCLUSIONS: Patients who underwent direct-to-implant prepectoral breast reconstruction demonstrated an overall satisfaction with their outcomes. As prepectoral breast reconstruction continues to advance and grow in popularity, patient-reported outcomes such as those presented in this study become of paramount importance in practice. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Safran T, Al-Halabi B, Viezel-Mathieu A, et al. Direct-to-Implant Prepectoral Breast Reconstruction: Patient-Reported Outcomes. Plast Reconstr Surg. 2021. PMID: 34847107. doi:10.1097/PRS.0000000000008506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。